Growth Opportunities in Global Biosimilars Market, Forecast to 2028

Chemicals and Materials Growth Opportunities in Global Biosimilars Market, Forecast to 2028

Increasing Access, Adoption, and Awareness are the Key to Future Growth Potential of Biosimilars


RELEASE DATE
26-Sep-2023
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
PF0F-01-00-00-00
SKU
CM_2023_187
Yes
SHARE

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
CM_2023_187

Growth Opportunities in Global Biosimilars Market, Forecast to 2028
Published on: 26-Sep-2023 | SKU: CM_2023_187

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Biosimilar acceptance and use are increasing as patients and healthcare providers improve their understanding and awareness of therapeutic agents driven by biosimilar manufacturers and regulators. As the availability of information and practical data supporting the safety and effectiveness of biosimilars increases, both patients and healthcare professionals are developing a greater level of confidence in these medications. It is imperative for pharmaceutical companies to delicately navigate the intricate balance between safeguarding their biologic products and cultivating an environment conducive to the presence of biosimilars, which inevitably contribute to a thriving competitive milieu.

This study presents overall market and segment-wise revenue forecasts for the global biosimilars market. It highlights key growth opportunities for biosimilar market participants based on the trends, evolution of business models, and strategic imperatives for various stakeholders. It identifies the greatest revenue-generating therapeutic areas and product types. The elements affecting regional biosimilar uptake and biosimilar market entrance have been clearly stated. In addition, this report covers complicated factors, including reimbursement and payer landscape, biosimilar price trends, and biosimilar sales trends that will affect biosimilar penetration. The study discusses regional biosimilar discrepancies as well as industry issues, including physician adoption and patent litigations. This report identifies key growth opportunities to increase biosimilar uptake and innovations and compete for newer therapy areas, such as neurology and oncology.

Author: Surbhi Gupta

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Global Biosimilars Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Market Segmentation

Key Regional Competitors in the Biosimilars Market

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Growth Restraints (continued)

Growth Restraints (continued)

Highlights—Biosimilars Regional Dynamics

Growth Opportunities—Biosimilars Market

Strategies to Boost Biosimilars Development and Adoption

Biopharma Taking Lead to Boost Adoption of Biosimilars—Sandoz

North America Competitive Benchmarking—Key Countries

Market Snapshot—US Biosimilar Market

Biosimilars Approved in the US

The US Healthcare Financial and Distribution Pathways

Business Model Transformation due to the Next Wave of Biosimilars

Evolving Roles of PBM Formularies to Boost Biosimilar Accessibility

Evolving US Biosimilar Regulatory Landscape

US Insulin Biosimilar Market Set for Major Reset in Response to IRA

Dual Pricing Strategy in the US

US Oncology

US Oncology Supportive Care

US Immunology and Ophthalmology

Europe Competitive Benchmarking—Key Countries

Market Snapshot—Europe Biosimilars Market

Biosimilars Approved in Europe

Biosimilars Approved in Europe (continued)

Swift and Rapid Adoption of Biosimilar—Denmark Success Story

Incentives Driving Adoption of Biosimilars

APAC and MEA Competitive Benchmarking—Key Countries

Market Snapshot—Key APAC and MEA Biosimilar Market

Intensifying Focus of Asian Biopharma and CDMO on the Global Market

Key Growth Metrics

Forecast Assumptions and Considerations—Biosimilars Market

Revenue Forecast—Global Biosimilars Market

Revenue Forecast Analysis—Global Biosimilars Market

Revenue Forecast by Product Type

Revenue Forecast Analysis by Product Type

Revenue Forecast by Therapeutic Area

New and Upcoming Key Biologics Patent Expiration

Revenue Forecast Analysis—Oncology

Revenue Forecast Analysis—Musculoskeletal and Immunology

Revenue Forecast Analysis—Endocrinology and Ophthalmology

Competitive Environment

Revenue share

Revenue Share Analysis

Growth Opportunity 1: RWE Solutions

Growth Opportunity 1: RWE Solutions (continued)

Growth Opportunity 2: Neurology Biosimilars

Growth Opportunity 2: Neurology Biosimilars (continued)

Growth Opportunity 3: Focus on the Middle East and Africa

Growth Opportunity 3: Focus on the Middle East and Africa (continued)

Growth Opportunity 4: Leveraging AI, PD, and Omics Biomarkers

Growth Opportunity 4: Leveraging AI, PD, and Omics Biomarkers (continued)

Growth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars

Growth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Chemicals and Materials research

24 Aug 2026   |   South Asia, Middle East & North Africa   |   Market Research

Growth Opportunities in the Indian Intermediate Chemicals Industry, 2025–2030

The analysis covers a portfolio of import-dependent chemical intermediates and downstream derivatives in India. The growth opportunities are categorized into three strategic buckets namely, scalable opportunities, conditional bets, and plausible MOAT. Each consists of chemical intermediates filtered...

17 Aug 2026   |   South Asia, Middle East & North Africa   |   Market Research

Growth Opportunities for Chlorine Derivatives, Middle East and North Africa, 2025–2030

This study assesses chlorine derivative opportunities across the MENA region. It analyzes the existing chlorine derivative landscape and identifies attractive specialty chlorine derivative opportunities.

A comprehensive chlorine derivative universe was established based on global chlorine con...

14 Aug 2026   |   Global   |   Market Research

Wood Coatings Market, Global, 2026–2032

Wood coatings are specialized protective and decorative finishes applied to wooden surfaces to enhance durability, improve aesthetic appeal, and protect against environmental and mechanical damage. Growth in the global construction sector continues to drive demand for wood coatings because of their ...

14 Aug 2026   |   Global   |   Technology Research

Innovations in Surface Technologies for Optical Coatings, Antifouling Coatings, Protective Coatings, Sustainable Packaging Coatings, and Others

This edition of the Advanced Coating & Surface Technology Opportunity Engine profiles significant advances in advanced coatings and surface treatments for various industrial applications. The featured innovations include Next-Generation Low-Emissivity Coatings for Lightweight Transparent Glazing, Pl...

13 Aug 2026   |   Global   |   Market Research

Vehicle Wraps Market, Global, 2025

The global vehicle wraps market is driven by the increasing demand for advertising, personalization, and paint protection. Traditionally dominated by commercial fleet branding, vehicle wraps have evolved significantly due to advancements in film technologies, digital printing systems, and changing c...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Biosimilar acceptance and use are increasing as patients and healthcare providers improve their understanding and awareness of therapeutic agents driven by biosimilar manufacturers and regulators. As the availability of information and practical data supporting the safety and effectiveness of biosimilars increases, both patients and healthcare professionals are developing a greater level of confidence in these medications. It is imperative for pharmaceutical companies to delicately navigate the intricate balance between safeguarding their biologic products and cultivating an environment conducive to the presence of biosimilars, which inevitably contribute to a thriving competitive milieu. This study presents overall market and segment-wise revenue forecasts for the global biosimilars market. It highlights key growth opportunities for biosimilar market participants based on the trends, evolution of business models, and strategic imperatives for various stakeholders. It identifies the greatest revenue-generating therapeutic areas and product types. The elements affecting regional biosimilar uptake and biosimilar market entrance have been clearly stated. In addition, this report covers complicated factors, including reimbursement and payer landscape, biosimilar price trends, and biosimilar sales trends that will affect biosimilar penetration. The study discusses regional biosimilar discrepancies as well as industry issues, including physician adoption and patent litigations. This report identifies key growth opportunities to increase biosimilar uptake and innovations and compete for newer therapy areas, such as neurology and oncology. Author: Surbhi Gupta
More Information
Deliverable Type Market Research
Author Surbhi Gupta
Industries Chemicals and Materials
No Index No
Is Prebook No
Keyword 1 Biosimilars In Healthcare
Keyword 2 Biosimilar Market Outlook
Keyword 3 Biopharma Growth Opportunities
Podcast No
Predecessor MF9D-01-00-00-00
WIP Number PF0F-01-00-00-00